![Kevin Shaw](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kevin Shaw
Algemeen Adviseur bij
NEXTCURE, INC.
Profiel
Kevin G.
Shaw is currently General Counsel at NextCure, Inc. since 2023.
Formerly, Mr. Shaw was Vice President & Deputy General Counsel at Precigen, Inc. from 2012 to 2022.
Education includes undergraduate studies at the University of Pennsylvania and graduate studies at George Washington University Law School.
Actieve functies van Kevin Shaw
| Bedrijven | Functie | Begin |
|---|---|---|
| NEXTCURE, INC. | Algemeen Adviseur | 01-05-2022 |
Eerdere bekende functies van Kevin Shaw
| Bedrijven | Functie | Einde |
|---|---|---|
| PRECIGEN, INC. | Corporate Officer/Principal | 01-05-2022 |
Opleiding van Kevin Shaw
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
36
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Precigen, Inc.
 Precigen, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
George Washington University Law School
 George Washington University Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NextCure, Inc.
 NextCure, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which discovers and develops novel immuno medicines to treat cancer & immune related diseases | Health Technology |
